The 2021 USCAP Annual Meeting will not happen in a city, a convention center or a hotel. It will happen throughout the world, across time zones, agnostic to borders, far-reaching, driven with energy, information and connectivity.
AM 2021 may be virtual, but it’s real USCAP.
Join us as we reinvent possible.
AMP Conference has been rescheduled to June 14 – 16, 2021
DIAGNOSTIC PATHOLOGY UPDATE 2020
USCAP is a transformative leader in pathology education, creating better pathologists with updates in relevant information requisite for their performance and professional growth. The Academy is sensitive to the personal and cultural needs of practicing pathologists by providing conferences that welcome them with their families to exotic destination venues at which they are enriched with new knowledge and unusual experiences. The 2020 Diagnostic Pathology Update course combines expert subspecialized, academic faculty with exposure to ocean and rain forests symbolic of the dichotomy that is Costa Rica. From zip-lining to surfing, this tropical paradise brings pathologists into contact with the cuisine, agriculture, art and geography of a unique country that values education as its primary core value. Costa Rica has eliminated its standing army to use the savings from defense to improve education, health care and a durable social safety net.
USCAP is changing not only how we learn, but where we learn by re-imagining the learning environment and continuously elevating the quality of content. Experience top educators. Refine cognitive skills. Hold coffee beans in your hand. Inhale vapor from raging waterfalls. Witness rainbows in the evanescent colors of iguana skins. Feel sunsets scalding your memory.
Course Director: Rhonda K. Yantiss, MD & Jason L. Hornick, MD, PhD
Hematopathology Tasting Menu: A Sampling of Delightful Diagnostic Challenges
The most recent (2016) WHO classification of hematologic neoplasms delineates specific diagnostic criteria for well-defined neoplastic entities. However, pathologists who diagnose bone marrow biopsies and lymphoid proliferations often face challenges that are not directly addressed by the WHO system or represent reactive conditions that may mimic hematologic malignancies. These include atypical morphologic features, unexpected immunostaining patterns, and discordant genetic features in neoplastic entities. Pathologists often have difficulties applying the WHO criteria if they are not fully concordant with the expected patterns and/or if they are relatively new entities with which pathologists may be unfamiliar. Moreover, there is inherent subjectivity in interpreting morphologic findings and even the results of ancillary testing. The literature contains reports about the intrinsic interobserver variability in making hematopathology diagnoses and pitfalls when applying established criteria. This course aims to bridge the practice gaps between the 'ideal world' WHO classification system and the 'real world' of hematopathology diagnosis by presenting challenging case examples.
These cases will illustrate how to interpret correctly and apply morphologic criteria in diagnosing hematologic neoplasms (including newer entities), how to avoid diagnosing malignancy in benign mimics, and how appropriately to integrate the results of ancillary testing with the morphology, particularly when there are discordant or unexpected results. We will provide participants with guidelines on how practically to approach such cases and avoid misdiagnosis, thereby improving their performance in daily practice. The target audience is general pathologists who diagnose bone marrow and lymphoid lesions, practicing hematopathologists and hematopathology fellows.
Course Location: Palm Springs, CA
Course Director: Robert P. Hasserjian, MD
Challenges in Hematopathology
Distinguishing between reactive and neoplastic proliferations in blood, bone marrow, lymph nodes, spleen and extra-nodal hematopoietic tissues, as well as accurately classifying neoplasms once they are identified, are essential for appropriate patient care. Pathologists struggle with differentiating reactive from neoplastic conditions in these organs, as well as in properly classifying hematopoietic neoplasms once they are diagnosed. This highly respected expert faculty will provide a unique mentoring experience in an intimate study environment at USCAP’s Interactive Learning Center. They intend to cover diagnostic criteria for new entities in the 2016 WHO Classification of Hematopoietic and Lymphoid Neoplasms and provide useful morphologic clues and ancillary techniques to help you distinguish neoplastic and reactive conditions..
Course Location: Palm Springs, CA
Course Director: Daniel A. Arber, MD